These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 1375300

  • 21. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR, Meline JA, Ni RX, Keys M, Wu CH.
    Am J Pathol; 1987 Oct; 129(1):133-9. PubMed ID: 3499082
    [Abstract] [Full Text] [Related]

  • 22. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats.
    Shibasaki T, Gomi H, Ishimoto F, Sakai O.
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404
    [Abstract] [Full Text] [Related]

  • 23. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T, Kaneko K, Yamada T, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [Abstract] [Full Text] [Related]

  • 24. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H, Reivinen J, Solin ML, Haltia A, Miettinen A.
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [Abstract] [Full Text] [Related]

  • 25. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K, Sterzel RB, Reale E.
    J Submicrosc Cytol; 1981 Jul; 13(3):407-12. PubMed ID: 7334544
    [Abstract] [Full Text] [Related]

  • 26. Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
    Abrahamson DR, Hein A, Caulfield JP.
    Lab Invest; 1983 Jul; 49(1):38-47. PubMed ID: 6865329
    [Abstract] [Full Text] [Related]

  • 27. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
    Garin EH, Shirey AJ.
    Child Nephrol Urol; 1983 Jul; 9(3):121-6. PubMed ID: 2978121
    [Abstract] [Full Text] [Related]

  • 28. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985 Jul; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

  • 29. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM.
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [Abstract] [Full Text] [Related]

  • 30. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K, Matsui K, Nagase M.
    Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
    [Abstract] [Full Text] [Related]

  • 31. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
    Shibasaki T, Matsuda H, Gomi H, Usui M, Ishimoto F, Sakai O.
    Am J Nephrol; 1996 Jun; 16(2):167-72. PubMed ID: 8919236
    [Abstract] [Full Text] [Related]

  • 32. Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy.
    Fawcett JP, Jiang R, Walker RJ.
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):227-34. PubMed ID: 7881871
    [Abstract] [Full Text] [Related]

  • 33. Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis.
    Egashira Y, Nagaki S, Sanada H.
    Int J Vitam Nutr Res; 2006 Jan; 76(1):28-33. PubMed ID: 16711654
    [Abstract] [Full Text] [Related]

  • 34. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Nephron Exp Nephrol; 2010 Jan; 116(1):e3-10. PubMed ID: 20502051
    [Abstract] [Full Text] [Related]

  • 35. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H.
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [Abstract] [Full Text] [Related]

  • 36. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC.
    Nephron; 1993 Dec; 65(3):418-25. PubMed ID: 8289993
    [Abstract] [Full Text] [Related]

  • 37. [Mechanism of reduction in proteinuria by cyclosporine A: effects on the glomerular anionic sites].
    Tanabe T.
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):377-83. PubMed ID: 2227790
    [Abstract] [Full Text] [Related]

  • 38. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
    Hattori T, Ito M, Suzuki Y.
    Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
    [Abstract] [Full Text] [Related]

  • 39. [N-acetyl-beta-D-glucosaminidase (NAG) activity and low molecular weight urinary proteins in rats with puromycin-aminonucleoside (PAN)-induced nephrosis].
    Asakura S, Terukina S, Kato K, Taki Y, Asano Y.
    Nihon Jinzo Gakkai Shi; 1987 Nov; 29(11):1443-52. PubMed ID: 3450901
    [No Abstract] [Full Text] [Related]

  • 40. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
    Rada JA, Carlson EC.
    Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.